News-Medical.Net on MSN

New breakthrough could modernize treatment for glioblastoma

Researchers at the UNC School of Medicine and the UNC Eshelman School of Pharmacy have made a breakthrough that could ...
WSB-TV

What is glioblastoma? What you need to know about the brain tumor

Glioma are tumors of the brain, and glioblastoma is a grade IV glioma — the most aggressive form of the disease. The glioma is formed from abnormal astrocyte cells, which are those that support many ...
Science Daily

Breakthrough in treatment approach showing promise in the fight against glioblastoma

Medical researchers have announced the results of an innovative treatment approach that may offer improvement in overall survival in older patients with newly diagnosed glioblastoma while maintaining ...
Nasdaq

CNS Pharmaceuticals (NASDAQ: CNSP) Presents Updated Results from On-Going Potentially Pivotal Study of Berubicin in Adult Patients with Recurrent GBM (WHO Grade IV) After ...

Berubicin currently being evaluated in an ongoing potentially pivotal study for the treatment of Glioblastoma Multiforme (GBM) with topline data from interim analysis expected before year end HOUSTON, ...
Seeking Alpha

CNS Pharmaceuticals Presents Update from Ongoing Potentially Pivotal Study of Berubicin Compared with Lomustine in Adult Patients with Recurrent GBM (WHO Grade IV) After ...

Primary analysis data in potentially pivotal GBM study with lead program, Berubicin, on track for the first half of 2025 The poster titled, "Update on a Potentially Pivotal Trial CNS-201: A Randomized ...
Nasdaq

CNS Pharmaceuticals Presents Update from Ongoing Potentially Pivotal Study of Berubicin Compared with Lomustine in Adult Patients with Recurrent GBM (WHO Grade IV) After ...

HOUSTON, TX / ACCESSWIRE / November 25, 2024 / CNS Pharmaceuticals, Inc. (NASDAQ:CNSP) ("CNS" or the "Company"), a biopharmaceutical company specializing in the development of novel treatments for ...